Skip to Main Content
Skip Nav Destination

Red Book Online News

August 11, 2022

Check the Red Book Online News page often for breaking news related to pediatric infectious diseases and immunizations, including new vaccine recommendations, vaccine or antiviral shortages, product recalls, disease outbreaks, travel notices, and more. 


August 2022

CDC COCA Call: CDC and FDA Update—Interim Clinical Considerations for Monkeypox Vaccination Posted 8/11/22

Durng this COCO Call, presenters from FDA and CDC will provide updates on FDA’s EUA of the JYNNEOS vaccine and CDC’s Interim Clinical Considerations for using the JYNNEOS and ACAM2000 Vaccines during the 2022 U.S. Monkeypox Outbreak. Presenters will also provide training on how to administer the vaccines using the interim clinical considerations.

Date: Thursday, August 11, 2022
Time: 3:00 – 4:00 PM ET

For additional information and to view this session, please visit the CDC Emergency Preparedness and Response website at https://emergency.cdc.gov/coca/calls/2022/callinfo_081122.asp


Red Book Online Outbreaks Update: Small Turtles – Salmonella Infections Posted 8/2/22
Officials are currently investigating a multistate outbreak of Salmonella infections linked to small turtles.

A new entry on this Salmonella outbreak has been added to the Red Book Online Outbreaks page, providing information about the outbreak and its impacts for the pediatric population.

Overseen by members of the AAP Committee on Infectious Diseases, the Red Book Online Outbreaks page is intended to provide pediatric health care professionals with a quick resource to get up to speed on current outbreaks and how they affect children, along with links to explore further.

Bookmark the page for regular visits, and keep an eye out for emails from Red Book Online alerting you to updates.


July 2022

CDC COCA Call: Recommendations for the Novavax COVID-19 Primary Series in Adults Ages 18 and Older Posted 7/21/22
During this COCA Call, presenters will discuss CDC’s new guidance on the Novavax COVID-19 vaccine for adults ages 18 years and older, including adults who are moderately or severely immunocompromised.
Free Continuing Education (CE) will be offered for this COCA Call. Registration is not required.

Date: Thursday, July 28, 2022
Time: 2:00 – 3:00 PM ET

For additional information and to view this session, please visit the CDC Emergency Preparedness and Response website at https://emergency.cdc.gov/coca/calls/2022/callinfo_072822.asp


Updates to RBO Vaccine Status Tables Posted 7/14/22
Red Book Online (RBO) Vaccine Status Tables contain current information about recently submitted, licensed, and recommended vaccines and biologics, including status of the US Food and Drug Administration (FDA) licensure process and related American Academy of Pediatrics (AAP) and Centers for Disease Control and Prevention (CDC) recommendations.

Information in the Vaccine Status Tables was just updated. Updates include the following:

Table 1. Status of Recently Submitted, Licensed, and Recommended Vaccines & Biologics

  • Measles, Mumps, Rubella: New entry
  • PCV15
    • New AAP/CDC recommendations
    • Updated FDA age indication and licensure date

 Table 2. Status of Recently Submitted, Licensed, and Recommended Influenza Vaccines

  • IIV4 (Fluzone High-Dose Quadrivalent) and IIV4 (Fluad Quadrivalent): Updated comments regarding age preference
  • RIV4 (Flublock Quadrivalent): New vaccine

 Table 3. Sars-CoV-2 Vaccines

  • mRNA162b2
    • Updated storage requirements
    • New guidance for ages 6 months through 4 years
    • New Biologics License Application (BLA) status for ages 12 through 15 years
  • mRNA-1273: New guidance for ages 12 through 17 years, 6 through 11 years, and 6 months through 5 years

CDC Issues Advisory on Parechovirus Infections in Infants Posted 7/13/22
Health officials are asking clinicians to be on the lookout for infants with parechovirus (PeV) infection following reports of infections in multiple states.

PeV should be considered in infants with fever, sepsis-like syndrome, or neurological illness such as seizures or meningitis without another known cause (see the health advisory from the Centers for Disease Control and Prevention [CDC]).

Clinicians should test for PeV in children with symptoms. Testing is available at commercial clinical laboratories and state public health laboratories. Hospitals also may use multiplex meningitis and encephalitis panels for cerebrospinal fluid testing that include PeV. The CDC can test samples in some cases, but clinicians should work with their state officials and email PicornaLab@cdc.gov before submitting specimens.

See the full article, including resources, in AAP News.

Also see AAP Red Book Chapter: Parechovirus Infections.


Red Book Online Outbreaks Update: Listeria Outbreak Linked to Ice Cream Posted 7/6/22
Officials are currently investigating a multistate outbreak of Listeria monocytogenes linked to ice cream.

A new entry on this Listeria outbreak has been added to the Red Book Online Outbreaks page, providing information about the outbreak and its impacts for the pediatric population.

Overseen by members of the AAP Committee on Infectious Diseases, the Red Book Online Outbreaks page is intended to provide pediatric health care professionals with a quick resource to get up to speed on current outbreaks and how they affect children, along with links to explore further.

Bookmark the page for regular visits, and keep an eye out for emails from Red Book Online alerting you to updates.


June 2022

Red Book Online Outbreaks Update: Meningococcal Disease and Monkeypox Posted 6/30/22
Officials are currently investigating two outbreaks—an outbreak of meningococcal disease in Florida and an outbreak of monkeypox infections in the United States.

New entries on these two outbreaks have been added to the Red Book Online Outbreaks page, providing information about the outbreaks and their impact for the pediatric population.

Overseen by members of the AAP Committee on Infectious Diseases, the Red Book Online Outbreaks page is intended to provide pediatric health care professionals with a quick resource to get up to speed on current outbreaks and how they affect children, along with links to explore further.

Bookmark the page for regular visits, and keep an eye out for emails from Red Book Online alerting you to updates.


CDC COCA Call: Monkeypox – Updates about Clinical Diagnosis and Treatment Posted 6/27/22
This COCA Call will present what clinicians need to know about monkeypox including guidance about the typical clinical presentation, treatment options, pre- and post-exposure prophylaxis, and reporting to public health authorities.

Date: Wednesday, June 29, 2022
Time: 2:00 – 3:00 PM ET

For additional information and to view this session, please visit the CDC Emergency Preparedness and Response website at https://emergency.cdc.gov/coca/calls/2022/callinfo_062922.asp


AAP COVID-19 Town Hall: Special White House Guest Posted 6/27/22
Join the next AAP Town Hall on Thursday, June 30 at 7 pm CT for a session focused on COVID-19 vaccines. We are delighted to announce that B. Cameron Webb, MD, JD, Senior Advisor on the White House COVID-19 Response Team will be joining as a special guest.

This bi-weekly series of virtual town halls links members with leading experts to discuss emerging issues related to the COVID-19 pandemic.

Expert Panelists
James Campbell, MD, MS, FAAP
Member, AAP Committee on Infectious Diseases
Professor, Center for Vaccine Development and Global Health, University of Maryland School of Medicine

Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Epidemiology and Population Health;
Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development and Diversity, Stanford University School of Medicine 

Register here.


CDC COCA Call: Recommendations for Pfizer-BioNTech and Moderna COVID-19 Vaccine Primary Series in Children 6 Months through 5 Years Old Posted 6/21/22
While children have a lower risk for severe COVID-19 compared to adults, they can get COVID-19, spread it to others, and become seriously ill. COVID-19 vaccination provides protection to children and adolescents against severe illness and outcomes associated with COVID-19, including emergency department or urgent care visits, hospitalizations, and death.

During this COCA Call, presenters will discuss CDC’s new guidance on the pediatric COVID-19 vaccine primary series for children ages 6 months through 4 years old for Pfizer-BioNTech and ages 6 months through 5 years old for Moderna, including children who are moderately or severely immunocompromised.

Date: Wednesday, June 22, 2022
Time: 2:00 – 3:00 PM ET

For additional information and to view this session, please visit the CDC Emergency Preparedness and Response website at https://emergency.cdc.gov/coca/calls/2022/callinfo_062222.asp


Red Book Online Outbreaks Update: Backyard Poultry – Salmonella Infections Posted 6/15/22
Officials are currently investigating a multistate outbreak of Salmonella infections linked to backyard poultry.

A new entry on this Salmonella outbreak has been added to the Red Book Online Outbreaks page, providing information about the outbreak and its impacts for the pediatric population.

Overseen by members of the AAP Committee on Infectious Diseases, the Red Book Online Outbreaks page is intended to provide pediatric health care professionals with a quick resource to get up to speed on current outbreaks and how they affect children, along with links to explore further.

Bookmark the page for regular visits, and keep an eye out for emails from Red Book Online alerting you to updates.


Updates to RBO Vaccine Status Tables Posted 6/1/22
Red Book Online (RBO) Vaccine Status Tables contain current information about recently submitted, licensed, and recommended vaccines and biologics, including status of the US Food and Drug Administration (FDA) licensure process and related American Academy of Pediatrics (AAP) and Centers for Disease Control and Prevention (CDC) recommendations.

Information in the Vaccine Status Tables was just updated. Updates include the following:

Table 1. Status of Recently Submitted, Licensed, and Recommended Vaccines & Biologics

  • Hepatitis B Vaccine, PreHevbrio: New information

 Table 3. Sars-CoV-2 Vaccines

  • mRNA162b2, mRNA-1273, and Ad26COV51: Extensive dose number and interval updates; includes updates for all ages and immunocompromised
  • mRNA162b2: FDA status update: booster authorized for emergency use (“EUA 5/17/2022—booster”)
  • mRNA-1273: Update to presentation

Red Book Online Outbreaks Update: Salmonella Infections Linked to Peanut Butter Posted 6/1/22
Officials are currently investigating a multistate outbreak of Salmonella Senftenberg infections linked to Jif brand peanut butter.

A new entry on this Salmonella Senftenberg outbreak has been added to the Red Book Online Outbreaks page, providing information about the outbreak and its impacts for the pediatric population.

Overseen by members of the AAP Committee on Infectious Diseases, the Outbreaks page is intended to provide pediatric health care professionals with a quick resource to get up to speed on current outbreaks and how they affect children, along with links to explore further.

Bookmark the page for regular visits, and keep an eye out for emails from Red Book Online alerting you to updates.


May 2022

AAP COVID-19 Town Hall Posted 5/23/22
Join the next AAP Town Hall on Thursday, May 26 at 7 pm CT. This bi-weekly series of virtual town halls links members with leading experts to discuss emerging issues related to the COVID-19 pandemic.   

Expert Panelists
Elizabeth Alderman, MD, FAAP
Chairperson, Committee on Adolescence 
Chief, Division of Adolescent Medicine at the Children’s Hospital at Montefiore and founder of the Montefiore Adolescent Primary Care Initiative 

James Campbell, MD, MS, FAAP
Member, AAP Committee on Infectious Diseases
Professor, Center for Vaccine Development and Global Health, University of Maryland School of Medicine

Kimberly Montez, MD, MPH, FAAP 
Assistant Professor of Pediatrics, Assistant Program Director, Pediatrics Residency, Associate Director of Integrating Special Populations, Maya Angelou Center for Health Equity at Wake Forest School of Medicine; 
Vice Chair, Council on Community Pediatrics, American Academy of Pediatrics 

Register here.


CDC Adds 71 Cases of Pediatric Hepatitis to Investigation Posted 5/20/22
The Center for Disease Control and Prevention (CDC) is investigating an additional 71 cases of hepatitis without a known cause in children, bringing the total to 180.

Many of the 71 cases are newly reported but occurred months ago. The CDC is looking into cases dating back to October 2021. Those under investigation come from 36 states and territories.

About 9% have required liver transplants, down from 15% as reported earlier this month. At least five children have died, but no deaths have been reported since February.

In April, the CDC issued a health advisory regarding nine pediatric hepatitis cases of unknown etiology in Alabama from October 2021 through February 2022. None had documentation of a previous COVID-19 infection or COVID-19 vaccine. All were positive for adenovirus.

Among the 180 cases nationwide now under investigation, nearly half have had an adenovirus infection, and the CDC said it “continues to be a strong lead.” It also is looking at other possible pathogens including SARS-CoV-2.

For the full article and additional resources, please see AAP News.

Find more information about the hepatitis cases and clinical guidance on Red Book Online Outbreaks


CDC COCA Call: Clinical Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology Posted 5/12/22
The Centers for Disease Control and Prevention (CDC) is investigating a cluster of children identified with hepatitis and adenovirus infection. The CDC has recommended that US clinicians who encounter pediatric patients with hepatitis of unknown etiology consider adenovirus testing and report such cases to state public health authorities and the CDC. While there have been case reports of hepatitis in immunocompromised children with adenovirus type 41 infection in the past, adenovirus type 41 is not known to be a cause of hepatitis in otherwise healthy children. More common causes for hepatitis have been ruled out.

During this COCA Call, presenters will discuss the unknown etiology of patients under investigation, progress of the investigation, and how clinicians can continue to support these efforts through testing and reporting.

Date: Thursday, May 19, 2022
Time: 2:00 – 3:00 PM ET

For additional information and to view this session, please visit the CDC Emergency Preparedness and Response website at https://emergency.cdc.gov/coca/calls/2022/callinfo_051922.asp.


Red Book Online—New Content, New Resources Posted 5/12/22

RBO Influenza Resources Page—New Format, New Content
The Red Book Online (RBO) Influenza Resources page is updated weekly to include the most recent influenza information from the American Academy of Pediatrics (AAP) and Centers for Disease Control and Prevention. This page was reformatted to find pertinent information quickly by breaking up the content into the following sections:

  • Influenza News
  • Policy & Clinical Guidance
  • Implementation Resources
  • Professional Education & Resources
  • Social Media Resources
  • Patient Education

The AAP Committee on Infectious Diseases compiled this comprehensive list of influenza resources to serve as a centralized point of reference for the latest influenza-related news, vaccine guidance, prevention, treatment, policies, and other influenza information pertaining to infants, children, adolescents, and young adults.

New RBO Outbreak—Hepatitis Cases Possibly Associated with Adenoviral Infection
Officials are currently investigating a cluster of children in the US who have been diagnosed with hepatitis possibly associated with an adenoviral infection.

This outbreak has been added to the Red Book Online Outbreaks page, providing information about the outbreak and its impacts for the pediatric population.

Overseen by members of the AAP Committee on Infectious Diseases, the Outbreaks page is intended to provide pediatric health care professionals with a quick resource to get up to speed on current outbreaks and how they affect children, along with links to explore further.

Bookmark this page for regular visits, and keep an eye out for emails from Red Book Online alerting you to updates.

New Red Book Online Webinars
Two new webinars were posted to the Red Book Online Webinars page and are available to view.

  • Now More Than Ever: Updates to the 2022 Children and Adolescent Immunization Schedule
    Henry "Hank" Bernstein, DO, MHCM, FAAP discusses the Recommended Childhood and Adolescent Immunization Schedule: United States, 2022, including review of the schedule and rationale for the latest updates to it, as well as COVID-19 vaccines in children.
  • Planning for the Next Influenza Season: Pre-Booking
    Sheri Burnett, RN, Clinical Director at Plateau Pediatrics, provides an overview on what to consider when pre-booking influenza vaccines. This short webinar covers tips and strategies on pre-booking, such as reviewing vaccine manufacturer policies and considering lessons learned from the current influenza season to inform what vaccines to order for the next influenza season.

Systems-based Treatment Table
The Systems-based Treatment Table on Red Book Online assists pediatricians in using antibiotic agents appropriately and only when needed for the listed common pediatric conditions. To quickly access this table, go to the RBO home page and click on any of the three options provided (top dropdown Resources menu, Red Book 2021 box, or Systems-based Treatment Table box).


April 2022

Information on Hepatitis Cases Possibly Linked to Adenoviral Infection Posted 4/29/22
On April 21, 2022, the CDC issued a Health Alert Network advisory about a cluster of children in the U.S. who have been diagnosed with hepatitis possibly associated with an adenoviral infection. Find more information about the cases and clinical guidance on Red Book Online. Find information about other outbreaks on the Red Book Online Outbreaks page.


NEW PediaLink Course: Infection Prevention and Control for Pediatric Clinics Posted 4/26/22
Experience with COVID-19 has underscored the importance of infection prevention in the office. This includes applying Standard Precautions for all patient care, regardless of the patient’s suspected or confirmed infection status. All healthcare facilities should ensure that infection prevention and control actions are taken to minimize the risk of exposure to infectious diseases.

The purpose of this free course is to train pediatric practice managers on infection prevention and control (IPC) basics, and how to create safer environments for pediatric care teams, patients, and their families. Effective IPC measures start with a solid understanding of how infections are transmitted. Knowing how germs spread can help you to take action. This course will provide the tools and resources needed to develop and implement IPC practices in your office setting.

For more information and to register, go to shopAAP.


AAP COVID-19 Town Hall Posted 4/25/22
Join the next AAP Town Hall on Thursday, April 28th at 7 pm CT. This bi-weekly series of virtual town halls links members with leading experts to discuss emerging issues related to the COVID-19 pandemic.

Register here.


March 2022

PCO Webinar—Now More Than Ever: Updates to the 2022 Children and Adolescent Immunization Schedule Posted 3/25/22
We invite you to join us on Friday, April 8, at 1:00 pm ET when Henry (Hank) Bernstein, DO, MHCM, FAAP discusses the Recommended Childhood and Adolescent Immunization Schedule: United States, 2022. Objectives of this webinar include:

  • Review the Recommended Childhood and Adolescent Immunization Schedule for 2022.
  • Share the rationale for the latest updates to the immunization schedules.
  • Discuss COVID-19 vaccines in children.

To view the webinar on Friday, April 8, please click here or use the following url: https://event.webcasts.com/starthere.jsp?ei=1539525&tp_key=35cf7cb778

Henry (Hank) Bernstein, DO, MHCM, FAAP is a Professor of Pediatrics at the Zucker School of Medicine at Hofstra/Northwell in New York. He presently is a member of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the FDA, an ex-officio member of the AAP’s Committee on Infectious Diseases (Red Book Committee), and Associate Editor of Red Book Online. After recently completing his 4-year term as a member of the Advisory Committee on Immunization Practices (ACIP) of the CDC, he serves as a consultant to the ACIP’s COVID-19, Influenza, and Immunization Schedules Workgroups.

Dr. Bernstein taps into his extensive 37-year experience as a general pediatrician in private practice, the National Health Service Corps, and as Chief of General Academic Pediatrics at urban, suburban, and rural children’s hospitals to promote the health and well-being of children, their families, and communities.

His private, community-based primary care (generalist) experiences, in combination with academic leadership responsibilities, have provided him with a value-added, translational science perspective, unique from many others in academia.

This tacit knowledge enables him to fulfill a lifelong passion of communicating, educating, and translating science into clinical settings, educational venues, policymaking, and media interactions to advance the health of children.


AAP COVID-19 Town Hall Posted 3/14/22
Join the next AAP Town Hall on Thursday, March 17th at 7 pm CT. This bi-weekly series of virtual town halls links members with leading experts to discuss emerging issues related to the COVID-19 pandemic.

Expert Panelists

Sara Bode, MD, FAAP
Chairperson-elect, AAP Council on School Health
Medical Director, Nationwide Children's Hospital's Care Connection School-Based Health and Mobile Clinics

Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy;
Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine 

Carol Weitzman, MD, FAAP
Co-Director Autism Spectrum Center
Division of Developmental Medicine Boston Children's Hospital
Professor of Pediatrics at Yale

Register here.


2022 Childhood and Adolescent Immunization Schedule Now on RBO Posted 3/3/22
The Recommended Child and Adolescent Immunization Schedule, United States, 2022 is now available on Red Book Online (RBO). Approved by the Centers for Disease Control and Prevention (CDC), American Academy of Pediatrics, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, American College of Nurse-Midwives, American Academy of Physician Assistants, and National Association of Pediatric Nurse Practitioners, the schedules are revised annually to reflect current recommendations for the use of vaccines licensed by the US Food and Drug Administration.

  • Table 1 contains the recommended immunization schedule from birth to 18 years of age.
  • Table 2 is the catch-up immunization schedule for persons 4 months to 18 years of age who start late or who are more than 1 month behind the recommended age for vaccine administration.
  • Table 3 lists the vaccines that may be indicated for children and adolescents 18 years of age or younger on the basis of medical conditions.

The following changes (in alphabetical order) were made to individual vaccine footnotes on the schedule:

  • Dengue: A new section was added that contains information regarding routine recommendation for use of dengue vaccine.
  • Haemophilus influenzae type b (Hib): Text was edited to include recommendations for use of Vaxelis for routine and catch-up vaccination.
  • Hepatitis A: The note was updated to clarify the age for routine vaccination.
  • Human papillomavirus vaccination (HPV):
    • The note was updated to clarify when an HPV series is complete, and no additional dose of HPV is recommended.
    • The Special Situations section was updated to clarify persons with immunocompromising conditions (including HIV infection) should receive 3 doses of HPV vaccine, regardless of the age at initial vaccination.
  • Measles, mumps, and rubella (MMR): The section on routine vaccination was updated to include recommendations for the use of the combination measles, mumps, rubella, and varicella vaccine (MMRV).
  • Meningococcal serogroup A, C, W, and Y vaccines (MenACWY):
    • Text was added to clarify MenACWY vaccines can be simultaneously administered with serogroup B meningococcal (MenB) vaccines if indicated but at different anatomic sites, if feasible.
    • In the Special Situations section, the language for the dosing schedule for Menveo in infants was edited for clarity.

To see these and other notable changes to the 2022 Immunization Schedule, visit Red Book Online.

Additional Resources


Second Infant Death May Be Linked to Contaminated Formula Posted 3/2/22
A second infant death may be linked to contaminated powdered infant formula prompting another lot of Similac formula to be recalled, according to the U.S. Food and Drug Administration.

Some Similac, Alimentum and EleCare formulas are being recalled after four infants have had Cronobacter sakazakii infections and one had a Salmonella Newport infection after consuming the formula. The Abbott Nutrition powdered infant formulas were produced at the company’s Sturgis, Michigan, facility and distributed nationwide and internationally.

Consumers who have one of these powdered formulas should look for the code printed on the product packaging near the expiration date. They should not use the formula if it meets three criteria:

  • the first two digits of the code are 22 through 37; and
  • the code on the container contains K8, SH or Z2; and
  • the expiration date is 4-1-2022 (APR 2022) or later.

In addition, Similac PM 60/40 with lot code 27032K80 (can) / 27032K800 (case), is being recalled. It was distributed in the U.S. and Israel. Consumers can check if their formula is being recalled by visiting the company’s website and entering the lot code.

For the full article and additional resources, please see AAP News.


AAP COVID-19 Town Hall Posted 3/1/22
Join the next AAP Town Hall on Thursday, March 3, at 7:00 pm CT. This bi-weekly series of virtual town halls links members with leading experts to discuss emerging issues related to the COVID-19 pandemic.

Expert Panelists
David W. Kimberlin, MD, FAAP
Editor, AAP Red Book
Sergio Stagno, MD Endowed Chair in Infectious Diseases
Co-Director of the Division of Pediatric Infectious Diseases; and Vice Chair for Clinical and Translational Research at University of Alabama at Birmingham

Ruth Lynfield, MD, FAAP
Associate Editor, AAP Red Book 
State Epidemiologist and Medical Director at the Minnesota Department of Health

Register here.


February 2022

AAP COVID-19 Town Hall Posted 2/11/22
Join the next AAP Town Hall on Thursday, February 17, at 7:00 pm CT. This bi-weekly series of virtual town halls links members with leading experts to discuss emerging issues related to the COVID-19 pandemic.

Expert Panelists
James Campbell, MD, MS, FAAP
Member, AAP Committee on Infectious Diseases
Professor, Center for Vaccine Development and Global Health, University of Maryland School of Medicine

Ruth Lynfield, MD, FAAP
AAP Red Book Associate Editor
State Epidemiologist and Medical Director at the Minnesota Department of Health

Sean O’Leary, MD, MPH, FAAP
Vice Chairperson, AAP Committee on Infectious Diseases 
Professor, Pediatrics, Sections of Pediatric Infectious Diseases and General Academic Pediatrics,
University of Colorado Anschutz Medical Campus, Children’s Hospital Colorado

Register here.


RBO Vaccine Status Table Updates and Red Book Errata Posted 2/3/22

Updates to RBO Vaccine Status Tables
Red Book Online (RBO) Vaccine Status Tables contain current information about recently submitted, licensed, and recommended vaccines and biologics, including status of the US Food and Drug Administration (FDA) licensure process and related American Academy of Pediatrics (AAP) and Centers for Disease Control and Prevention (CDC) recommendations.

Information in the Vaccine Status Tables was just updated. Updates include the following:

Table 1. Status of Recently Submitted, Licensed, and Recommended Vaccines & Biologics

  • Dengue: Center for Disease Control and Prevention/American Academy of Pediatrics (CDC/AAP) recommendations
  • Hepatitis B Vaccine: Newly added
  • PCV20 and PCV15: CDC/AAP recommendation; Further information

Table 2. Status of Recently Submitted, Licensed, and Recommended Influenza Vaccines

  • ccIIV4: FDA licensure; FDA age indications

Table 3. Sars-CoV-2 Vaccines

  • mRNA162b2: All criteria
  • mRNA-1273: Dose number and interval; Presentation
  • Ad26COV51: Dose number and interval; Further information
  • NVX-CoV2373: FDA status

Errata for Current Edition of Red Book on Red Book Online
The American Academy of Pediatrics has posted the following new errata for the current edition of Red Book on Red Book Online.

Section 1: Active and Passive Immunization
Pages 32-33: In the second paragraph of the “Multiple Vaccines Administered at the Same Time” section of the Active Immunization chapter, the following correction has been made.

Corrected Text: “therefore, injectable and nasally-administered live-virus vaccines not administered on the same day should be given at least 28 days (4 weeks) apart whenever possible (Table 1.9). Live oral vaccines…”

Original Text: “therefore, live-virus vaccines not administered on the same day should be given at least 28 days (4 weeks) apart whenever possible (Table 1.9). This restriction does not apply to the nasally administered live attenuated influenza vaccine, which does not interfere with immune responses to MMR or varicella vaccination. In addition, live oral vaccines…”

Section 4. Antimicrobial Agents and Related Therapy

Page 982: In Table 4.11, in the Neurocysticercosis section, the following correction has been made to the Adult Dosage.

Corrected Text: “15 mg/kg/day (max 800 mg/day OR 1200 mg/day, depending on number and characteristics of lesions as detailed in IDSA guideline) for 10-14 days (take with food)”.

Original Text: “≥60 kg: 400 mg, orally, 2 times/day for 10–14 days (take with food) <60 kg: 15 mg/kg/day (max 1200 mg/day), orally, divided 2 times/day for 10–14 days (take with food)”

Page 982: In Table 4.11, in the Neurocysticercosis section, the following correction has been made to the Pediatric Dosage.

Corrected Text: “15 mg/kg/day (max 800 mg/day OR 1200 mg/day, depending on number and characteristics of lesions as detailed in IDSA guideline) for 10–14 days (take with food)”

Original Text: “15 mg/kg/day (max 1200 mg/day), orally, in 2 divided doses for 8–30 days (take with food)”

Page 989: The following corrections have been made to footnote 66.

Corrected Text: “The Centers for Disease Control and Prevention recommends 15 days of therapy, and suggests that more prolonged treatment courses (e.g. 30 days of albendazole, which may be repeated) may be needed for extraparenchymal or extensive disease.”

Original Text: “Longer courses may be needed for subarachnoid disease.”

Corrected Text: “Regimens such as dexamethasone (adult dose: 6 mg per day) for 10 days, beginning before starting anti-parasitic therapy, have been used.”

Original Text: “Regimens such as dexamethasone 6 mg/kg/day for 10 days, beginning before starting anti-parasitic therapy, and prednisone 1–1.5 mg/kg/day during therapy have been used.”

The full text of all new Red Book errata, including a PDFs from which pages can be printed and placed in print copies, is posted on Red Book Online. All users of the Red Book are encouraged to go to the Red Book Online errata page to view the errata. The errata are freely accessible to all visitors to the site. 


January 2022

AAP COVID-19 Town Hall Posted 1/31/22
Join the next AAP Town Hall on Thursday, February 3, at 7:00 pm CT. This bi-weekly series of virtual town halls links members with leading experts to discuss emerging issues related to the COVID-19 pandemic.

The February 3 event will feature experts in infectious diseases, sports medicine, and post-COVID conditions (long COVID).

Expert Panelists
Susannah “Suz” Briskin, MD, FAAP
Executive Committee Member, AAP Council on Sports Medicine and Fitness
Associate Professor of Pediatrics in the Division of Sports Medicine at Rainbow Babies and Children’s Hospital
Head Team Physician for Hathaway Brown School and Assistant Team Physician for Case Western Reserve University

Sarah Risen, MD, FAAP
Faculty, Department of Pediatric Neurology and Meyer Center for Developmental Pediatrics, Texas Children’s Hospital
Assistant Professor, Baylor College of Medicine

José R. Romero, MD, FAAP, FAAAS, FIDSA, FPIDS
Member, AAP Committee on Infectious Diseases
Immediate Past Chairperson, CDC Advisory Committee on Immunization Practices
Arkansas Secretary of Health; Director, Arkansas Department of Health
Professor of Pediatrics, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences

Register here.


AAP COVID-19 Town Hall Posted 1/18/22
Join the next AAP Town Hall on January 20 at 7:00 pm CT. This bi-weekly series of virtual town halls links members with leading experts to discuss emerging issues related to the COVID-19 pandemic. During this event, we will address the latest related to the COVID-19 pandemic.

Join us for this informative session where you will hear from leading experts and connect with your peers.

Sara Bode, MD, FAAP
Chairperson-elect, AAP Council on School Health
Medical Director, Nationwide Children's Hospital's Care Connection School-Based Health and Mobile Clinics

Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy;
Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine 

Joelle Simpson, MD, MPH, FAAP
Executive Committee Member, AAP Council on Children and Disasters
Chief of Emergency Medicine and Medical Director for Emergency Preparedness, Children’s National Hospital

Register here.


CDC COCA Call: COVID-19 Quarantine and Isolation Recommendations Posted 1/12/22
On Thursday, January 13, at 2:00 pm ET, the Centers for Disease Control and Prevention will host a COCA Call to review the recently updated COVID-19 quarantine and isolation recommendations for healthcare and non-healthcare settings. During this COCA Call, presenters will discuss the science supporting these changes, the populations and settings to which these changes apply, and additional precautions people should take at the end of quarantine or isolation.

Date: Thursday, January 13, 2022
Time: 2:00 – 3:00 PM ET

For additional information and to view this session, please visit the Centers for Disease Control and Prevention Emergency Preparedness and Response website at https://emergency.cdc.gov/coca/calls/2022/callinfo_011322.asp


CDC COCA Call: What Clinicians Need to Know About the New Oral Antiviral Medications for COVID-19 Posted 1/11/22
The emergency use authorizations (EUAs) for the new oral antiviral medications molnupiravir and Paxlovid™ (nirmatrelvir/ritonavir) supplement current therapeutic efforts to decrease hospitalizations and prevent severe COVID-19 and death. During this COCA Call, presenters from the Centers for Disease Control and Prevention, Office of the Assistant Secretary for Preparedness and Response, U.S. Food and Drug Administration, and the National Institutes of Health (NIH) will describe the recent EUAs and NIH treatment guidelines, patient prioritization, and resources for healthcare providers. Subject matter experts will review when to prescribe antiviral medications including patient assessment, how to have a risk-benefit discussion to address patient questions or concerns, and how to prioritize patients if medications are in short supply.

Date: Wednesday, January 12, 2022
Time: 2:00 – 3:00 PM ET

For additional information and to view this session, please visit the Centers for Disease Control and Prevention Emergency Preparedness and Response website at https://emergency.cdc.gov/coca/calls/2022/callinfo_011222.asp


Red Book Online Outbreaks Feature—New Format! Posted 1/6/22
Red Book Online Outbreaks continues to provide up-to-date information and resource links on current infectious disease outbreaks affecting the US pediatric population. This feature was recently reformatted and streamlined to quickly find pertinent and current outbreak information.

Overseen by members of the AAP Committee on Infectious Diseases, Red Book Online Outbreaks is intended to provide pediatric health care professionals with a quick resource to get up to speed on current outbreaks and how they affect the US pediatric population, along with links to explore further, and related Red Book chapters for additional information.

Visit Red Book Online to view all the current outbreaks, including the most recently posted Listeria outbreak linked to packaged salads by Dole and Fresh Express.

Red Book Online Outbreaks is regularly updated with new outbreaks and new information as each outbreak develops, as well as removal of outbreaks that have concluded.

Bookmark this feature for regular visits, and keep an eye out for emails from Red Book Online alerting you to updates.


CDC Reports First Pediatric Flu-related Deaths of 2021-’22 Season Posted 1/5/22
The first two pediatric influenza-associated deaths for the 2021-’22 season have been reported to the Centers for Disease Control and Prevention (CDC), according to Flu View, the CDC’s weekly surveillance report. Both deaths were reported in mid-December.

The first pediatric death was associated with an influenza A (H3) virus and occurred during the week ending December 11, 2021. The second pediatric death was associated with an influenza A virus, for which no subtyping was performed, and occurred during the week ending December 18, 2021.

The majority of viruses detected continue to be A(H3N2), according to the report. Most influenza A(H3N2) virus infections have occurred in children and young adults ages 5-24 years. However, the number of infections is increasing in other age groups as well.

While preliminary data suggest that vaccine effectiveness against currently circulating H3N2 viruses may be reduced this season, vaccination is still likely to offer some protection, including against serious flu illness and death.

The American Academy of Pediatrics (AAP) and CDC recommend everyone 6 months and older get vaccinated each year. Physicians with high-risk patients who have contracted the virus should treat them promptly with antivirals.

Read the full article in AAP News.


AAP COVID-19 Town Hall Posted 1/5/22
The AAP is proud to host the first Town Hall of 2022 on January 6th at 7:00 pm CT. This bi-weekly series of virtual town halls links members with leading experts to discuss emerging issues related to the COVID-19 pandemic. During this event, we will address the latest related to the COVID-19 pandemic. Join us for this informative session where you will hear from leading experts and connect with your peers.

James Campbell, MD, MS, FAAP
Member, AAP Committee on Infectious Diseases
Professor, Center for Vaccine Development and Global Health, University of Maryland School of Medicine

Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy;
Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine 

Sonja O’Leary, MD, FAAP
Chairperson, AAP Council on School Health
Assistant Professor, Pediatrics University of Colorado School of Medicine;
Medical Director, Denver Health, School-Based Health Centers

Register here.


December 2021

AAP COVID-19 Town Hall Posted 12/14/21
The AAP hosts a bi-weekly series of virtual town halls linking members with leading experts to discuss emerging issues related to the COVID-19 pandemic. The next session will be held on Thursday, December 16, 2021 at 7:00 pm CT. During this event, we will address the latest related to the COVID-19 pandemic. Join us for this informative session where you will hear from leading infectious disease experts and connect with your peers.

Expert Panelists
Kristine (Kris) Bryant, MD, FAAP
Member, AAP Committee on Infectious Diseases
Hospital Epidemiologist, Norton Children’s Hospital; Professor of Pediatrics, University of Louisville School of Medicine

James Campbell, MD, MS, FAAP
Member, AAP Committee on Infectious Diseases
Professor, Center for Vaccine Development and Global Health, University of Maryland School of Medicine

Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine 

Register here.


New Webinars on Red Book Online Posted 12/9/21
Visit Red Book Online (RBO) to view the following two new webinars!

Red Book Webinar on Increasing Influenza Vaccination Rates During the COVID-19 Pandemic
Annika M. Hofstetter, MD, PhD, MPH, FAAP provides an overview on increasing influenza vaccination rates during the COVID-19 pandemic in this webinar. This short webinar describes current influenza vaccination rates in children, common barriers to influenza vaccination, and strategies to improve timely influenza vaccination. View Webinar

Red Book Webinar on Tuberculosis Testing and Treatment in Children and Adolescents
Dawn Nolt, MD, MPH, FAAP, lead author of the AAP clinical report, "Tuberculosis Infection in Children and Adolescents: Testing and Treatment” published in the December 2021 issue of Pediatrics provides an overview of the recommendations on a newly recorded webinar. Topics include a change in terminology for tuberculosis infection (TBI), strategies for testing children and adolescents with suspected infection, and options for treatment for TBI. View Webinar

Find all AAP infectious disease-related webinars on the Red Book Online Webinars page, including “Red Book 2021 Key Updates” by David Kimberlin, MD, FAAP, Red Book Editor.


November 2021

Now Live—Red Book Online on New Unified Site Posted 11/30/21
All your trusted AAP resources, including Journals, News, Point-of-Care Solutions, and Books, are now all on one unified site, AAP Publications, offering unparalleled innovation with quick access to essential pediatric titles all in one place.

As part of Point-of-Care Solutions, Red Book Online (RBO) is on this unified site. Newly streamlined for ease of use and quick answer finding, RBO now has a new fresh look, including a redesigned home page where you will find pertinent features and key content at a glance, including the Red Book, COVID-19 Resources, Outbreaks, Influenza Resources, the Visual Library, and more.

Visit RBO today and discover newly enhanced layouts and functionality, such as split-screen viewing—view Red Book chapter text on the left and figures, images, tables, references, and related content and articles on the right.

Visit the new unified site or learn more at https://www.aap.org/pubscentral.


AAP COVID-19 Town Hall Posted 11/30/21
The AAP hosts a bi-weekly series of virtual town halls linking members with leading experts to discuss emerging issues related to the COVID-19 pandemic. The next session will be held on Thursday, December 2, 2021 at 7:00 pm CT. During this event, we will address the latest related to the COVID-19 pandemic and its impact on children, adolescents and families. Join us for this informative session where you will hear from leading experts and connect with your peers. Register here.   


AAP COVID-19 Town Hall Posted 11/15/21
Join us for our next AAP COVID-19 Town Hall on Thursday, November 18, at 7:00 pm CT to hear the latest about COVID-19 in children. This session will begin with a brief presentation from a National Institute for Child Health and Human Development (NICHD) pediatric leader, Dr. Robert Tamburro, who will provide a pediatric COVID-19 research update. The presentation will be followed by a time of facilitated Q&A. Join us for this informative session where you will hear from leading experts and connect with your peers. 

Register here. Previous town halls are available for viewing here.   

Expert Panelists
James Campbell, MD, MS, FAAP
Member, AAP Committee on Infectious Diseases
Professor, Center for Vaccine Development and Global Health
University of Maryland School of Medicine

Karen Puopolo, MD, PhD, FAAP
Chief, Section on Newborn Medicine, Pennsylvania Hospital
Associate Professor of Pediatrics
University of Pennsylvania Perelman School of Medicine

Robert F. Tamburro, MD, MSc, FAAP
Senior Advisor for Clinical Research, Division of Extramural Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development


COCA Call: What Clinicians, Pharmacists, and Public Health Partners Need to Know about Antibiotic Prescribing and COVID-19 Posted 11/11/21
The Centers for Disease Control and Prevention (CDC) has published several studies characterizing antibiotic prescribing during the COVID-19 pandemic in outpatient, nursing home, and hospital settings. Findings from these studies and others inform opportunities to improve antibiotic use and guide the development of resources to support healthcare professionals and health systems. Case studies representing common clinical scenarios will be discussed to support decisions related to antibiotic prescribing.

During this COCA Call, clinicians, pharmacists, and public health partners will learn about the impact of the COVID-19 pandemic on antibiotic prescribing and strategies for optimizing antibiotic prescribing.

Date: Thursday, November 18, 2021
Time: 2:00 PM – 3:00 PM ET

For additional information and to view this session, please visit the CDC Emergency Preparedness and Response website at https://emergency.cdc.gov/coca/calls/2021/callinfo_111821.asp.


AAP COVID-19 Town Hall Posted 11/3/21
Join us at a special time this Thursday, November 4, at 5:00 pm CT to connect with AAP infectious disease leaders to hear the latest about COVID-19 in children, including vaccines for 5-11 year olds.

View this and previous AAP Town Halls here.

Expert Panelists:  
Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine

Sean O’Leary, MD, MPH, FAAP
Vice Chairperson, AAP Committee on Infectious Diseases 
Professor, Pediatrics, Sections of Pediatric Infectious Diseases and General Academic Pediatrics,
University of Colorado Anschutz Medical Campus, Children’s Hospital Colorado


Red Book Online Outbreaks Update: Salmonella Infections Posted 11/2/21
Officials are currently investigating two multistate outbreaks of Salmonella infections linked to onions and salami sticks.

Two new entries on a Salmonella outbreak linked to onions and a Salmonella outbreak linked to salami sticks have been added to the Red Book Online Outbreaks section, providing information about the outbreaks and their impacts for the pediatric population.

Overseen by members of the AAP Committee on Infectious Diseases, the Outbreaks section is intended to provide pediatric health care professionals with a quick resource to get up to speed on current outbreaks and how they affect children, along with links to explore further.

Bookmark the section for regular visits, and keep an eye out for emails from Red Book Online alerting you to updates.


October 2021

The Next AAP COVID-19 Town Hall Posted 10/26/21
The AAP hosts a bi-weekly series of virtual town halls linking members with leading experts to discuss emerging issues related to the COVID-19 pandemic. The next session will be held on Thursday, October 28, 2021 at 7:00 pm CT. During this event, we will address the latest related to the COVID-19 pandemic and its impact on children, adolescents and families. We will also cover the vaccine roll-out for 5-11 year olds. Join us for this informative session where you will hear from leading experts and connect with your peers.

View this and previous AAP Town Halls here.


Red Book Online Outbreaks Update: Seafood – Salmonella Thomson Posted 10/21/21
Officials are currently investigating a multistate outbreak of Salmonella Thomson infections linked to seafood.

A new entry on this Salmonella Thomson outbreak has been added to the Red Book Online Outbreaks section, providing information about the outbreak and its impacts for the pediatric population.

Overseen by members of the AAP Committee on Infectious Diseases, the Outbreaks section is intended to provide pediatric health care professionals with a quick resource to get up to speed on current outbreaks and how they affect children, along with links to explore further.

Bookmark the section for regular visits, and keep an eye out for emails from Red Book Online alerting you to updates.


The Next AAP COVID-19 Town Hall Posted 10/13/21
The AAP hosts a bi-weekly series of virtual town halls linking members with leading experts to discuss emerging issues related to the COVID-19 pandemic. The next session will be held on Thursday, October 14, 2021 at 7:00 pm CT. During this event, we will address the latest related to the COVID-19 pandemic and its impact on children, adolescents and families. Join us for this informative session where you will hear from leading experts and connect with your peers.

Expert Panelists
Benson Hsu, MD, MBA, FAAP, FCCM
Chair-Elect, AAP Section on Critical Care
Professor of Pediatrics, University of South Dakota Sanford School of Medicine
Chief Scientific Officer, Preparedness Treatment and Equity Coalition

Kimberly Montez, MD, MPH, FAAP
Vice Chair, AAP Council on Community Pediatrics
Assistant Professor of Pediatrics; Associate Program Director, Pediatrics Residency; and Associate Director of Integrating Special Populations, Maya Angelou Center for Health Equity at Wake Forest School of Medicine

José R. Romero, MD, FAAP, FAAAS, FIDSA, FPIDS
Member, AAP Committee on Infectious Diseases
Immediate Past Chairperson, CDC Advisory Committee on Immunization Practices
Arkansas Secretary of Health; Director, Arkansas Department of Health
Professor of Pediatrics, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences

View this and previous AAP Town Halls here.


New PediaLink Course: Influenza During the COVID-19 Pandemic Posted 10/13/21
This four-part course series provides key information about the 2021-2022 flu season. The purpose of this PediaLink module is to educate pediatric health care professionals on the current American Academy of Pediatrics policy recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in infants, children, and adolescents. The recommendations for the prevention and treatment of influenza are updated annually.

Pediatricians continue to have a leadership role in the prevention of influenza and its complications through vaccine use and public education. In addition, pediatricians should promptly identify influenza infections to provide timely treatment when indicated to reduce childhood morbidity and mortality. Recommendations for treating egg-allergic patients are discussed along with requirements and importance for all health care personnel to be immunized annually.

Unit 1 Influenza: Clinical Presentation and Complications
Unit 2: Influenza: Diagnostic Testing
Unit 3: Prevention of Influenza
Unit 4: Influenza: Treatment for the Clinician

AVAILABLE: 10/11/2021 - 10/10/2022
https://shop.aap.org/influenza-during-the-covid-19-pandemic/

Faculty
Flor Munoz, MD, FAAP
Tim Uyeki, MD, MPH, MPP, FAAP
Claudette Poole. MD, FAAP
Julie A. Boom, MD, FAAP
Sean O'Leary, MD, MPH, FAAP
John M. Kelso, MD, FAAP,
Min Jung Lee, MD, FAAP
Suchitra Rao, MBBS, MSCS, FAAP
John Bradley, MD, FAAP


New PediaLink Course: Effective COVID-19 Vaccine Conversations Posted 10/12/21
The coronavirus disease 2019 (COVID-19) pandemic has caused tremendous burden to the U.S. population, including children and adolescents. Vaccines are safe and effective in protecting individuals and populations against infectious diseases, including COVID-19, and vaccines are currently available to provide protection against COVID-19. This course aims to improve knowledge and competency among pediatricians and non-physicians to have effective COVID-19 vaccine conversations with patients and families, including the sharing of credible COVID-19 vaccination information and responding to misinformation.

Module 1: Science of Vaccines & Common Myths
Module 2: COVID-19 Vaccine Basics: The Science of Vaccines
Module 3: Disinformation and Misinformation: Knowing the Difference—Coming Soon!
Module 4: Not Your Routine Vaccines, Not Your Routine Circumstances: Engaging with Patients and Parents About COVID-19 Vaccines in these Extraordinary Times
Module 5: Cognitive Biases, Behavior Change, and Putting the Evidence Into Action

Available: 10/8/21 – 12/31/21
https://shop.aap.org/effective-covid-19-vaccine-conversations/

Faculty
Rupali J. Limaye, PhD, MPH, MA
Sean O’Leary, MD, MPH, FAAP
Heidi J. Larson, PhD
Douglas J. Opel MD, MPH, FAAP

Learning Objectives

  •  Describe the science of vaccines and how they are developed, including COVID-19 vaccines.
  • Communicate effectively with adolescents and families who have questions or express hesitancy, providing them with accurate, succinct, and compelling responses to myths and frequently asked questions about COVID-19 vaccines.
  • Describe the difference between disinformation and misinformation and use strategies to address both.
  • Recognize and address cognitive biases about vaccines among patients and families by using effective messages and communication strategies to foster behavior change.

Acknowledgements
This program is supported by Cooperative Agreement Number 6-NU38OT000282-03-05, funded by the Center for State, Tribal, Local, and Territorial Support National Partnership Branch, Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Center for Disease Control and Prevention of the Department of Health and Human Services.


Coming Soon—Red Book Online on New Unified Site! Posted 10/6/21
Coming in November, all your trusted AAP resources, including Journals, News, Point-of-Care Solutions, and Books, are moving to one unified site offering unparalleled innovation with streamlined access to essential pediatric titles all in one place.

As part of Point-of-Care Solutions, Red Book Online (RBO) will be on this unified site. Newly streamlined for ease of use and quick answer finding, RBO will also have a new fresh look, including a redesigned home page and split screen content viewing. See below for a sneak peek.

New RBO Home Page—Find pertinent features and key content at a glance, including the Red Book, COVID-19 Resources, Outbreaks, Influenza Resources, the Visual Library, and more.

New Split Screen Functionality—View Red Book chapter text on the left and figures, images, tables, references, and related content and articles on the right.

Learn more about the new and exciting unified site at https://www.aap.org/pubscentral. And, be on the lookout for additional messaging about RBO on this new site.


Influenza Prevention and Control Strategies in Early Child Care Settings Posted 10/5/21
Influenza remains a serious threat to children due to its potential to cause severe morbidity and
mortality. Each year, millions of children get sick with seasonal flu, thousands are hospitalized, and
some die from complications. The best way to protect children against the flu is to get vaccinated,
along with implementing and teaching infection control practices. Join this webinar to learn how
child care settings can prepare for seasonal flu during the COVID-19 pandemic.

Thursday, October 7, 2021
5:00–6:00 pm ET

Register Online Now!

Presenter
Andrew Hashikawa, MD, MS, FAAP, Clinical Associate Professor of Emergency Medicine
and Pediatrics, Michigan Medicine, University of Michigan, Ann Arbor, MI

Target Audience

  • Head Start and child care center directors
  • Child care health consultants
  • Education services staff members
  • Health managers and specialists
  • Parent leaders

How to Register
Participation is free, but registration is required. Space is limited. Select this link to register.
After registering, participants will receive a confirmation email with details on how to join the
webinar. This webinar will be recorded and archived for later viewing.

Certificate of Participation
Participants will receive a certificate of participation upon completion of an online evaluation. A link
to the form will be available at the end of the webinar. Participants must complete the form in order
to receive a certificate.


COCA Call: 2021-2022 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Practitioners Posted 10/5/21
During this Clinician Outreach and Communication Activity (COCA) Call, subject matter experts from the American Academy of Pediatrics (AAP) and CDC will discuss strategies primary care providers and medical subspecialists can use to improve, prevent, and control influenza among children this season.

Date: Thursday, September 7, 2021
Time: 2:00 - 3:00 pm (ET)

Click here to watch this COCA Call.

 


September 2021

COCA Call: 2021-2022 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines Posted 9/16/21
During this Clinician Outreach and Communication Activity (COCA) Call, presenters will provide updates on the Advisory Committee on Immunization Practices (ACIP) recommendations for the 2021-2022 influenza vaccination season and guidance for coadministration of influenza and COVID-19 vaccines.

Date: Thursday, September 9, 2021
Time: 2:00 - 3:00 pm (ET)

For additional information and to view this session, please visit the Centers for Disease Control and Prevention Emergency Preparedness and Response website at
https://emergency.cdc.gov/coca/calls/2021/callinfo_090921.asp


Red Book Online Updates! Posted 9/7/21

RBO Vaccine Status Tables
The vaccine information in the Red Book Online Vaccine Status Tables (1 and 3) was updated to include new vaccines, usage recommendations, age indications, and US Food and Drug Administration (FDA) approval.

The Vaccine Status Tables contain current information about recently submitted, licensed, and recommended vaccines and biologics, including status of the FDA licensure process and related American Academy of Pediatrics (AAP) and Centers for Disease Control and Prevention (CDC)

  • Table 1: Status of Recently Submitted, Licensed, and Recommended Vaccines & Biologics
  • Table 2: Influenza Vaccines
  • Table 3: Sars-CoV-2 vaccines

See what’s new and visit often to stay updated on the latest vaccine information!

RBO Influenza Resource Page
The Influenza Resource Page was just updated to include the most recent influenza information from the AAP and CDC, including the just released AAP policy statement and technical report “Recommendations for Prevention and Control of Influenza in Children, 2021-2022.”

The AAP Committee on Infectious Diseases compiled this comprehensive list of influenza resources to serve as a centralized point of reference for vaccine guidance, prevention, treatment, payment, policies, news, and other information pertaining to influenza for infants, children, adolescents, and young adults.

This resource is updated frequently as needed, including pertinent information related to seasonal, H1N1, avian, and pandemic influenza.


The Next AAP Town Hall: COVID – How are the Children? Posted 9/7/21
The AAP hosts a bi-weekly series of virtual town halls linking members with leading experts to discuss emerging issues related to the COVID-19 pandemic. The next session will be held on Thursday, September 9, 2021 at 7:00 pm CDT. During this event, we will address the variety of impacts that COVID-19 is having on children and adolescents. Join us for this informative session where you will hear from leading experts and connect with your peers.

View this and previous AAP Town Halls here.


August 2021

AAP Town Hall: COVID – What's the Latest? Posted 8/31/21
The AAP hosts a bi-weekly series of virtual town halls linking members with leading experts to discuss emerging issues related to the COVID-19 pandemic. The next session will be held on Thursday, September 2, 2021 at 7:00 pm CT and will address the COVID-19 variants, monoclonal antibody treatment, vaccinations, back-to-school, and other pressing topics. Join us for this informative session where you will hear from leading experts and connect with your peers.

View this and previous AAP Town Halls here.


Available on RBO: AAP Interim Guidance on Use of Palivizumab During Unusual RSV Season
Posted 8/24/21
The American Academy of Pediatrics (AAP) recently released new interim guidance on the treatment of serious lower respiratory tract infections caused by respiratory syncytial virus (RSV). The guidance comes in response to an uncharacteristic rise in cases over the spring and summer. The AAP recommends consideration of the use of palivizumab, a monoclonal antibody directed against the fusion protein of RSV, in infants at increased risk of severe disease.

For complete information on RSV, refer to the Respiratory Syncytial Virus chapter in Red Book on Red Book Online.

Additional resources:


COCA Call: Additional mRNA COVID-19 Vaccines for Moderately to Severely Immunocompromised People Posted 8/16/21
The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUA) for additional doses of mRNA COVID-19 vaccines for moderately to severely immunocompromised people. People with immunocompromising conditions or who take immunosuppressive medications or therapies are at increased risk for severe COVID-19. Studies indicate that some immunocompromised people have a reduced immune response following a primary COVID-19 vaccine series compared to vaccine recipients who are not immunocompromised. Studies have further demonstrated that an additional mRNA COVID-19 vaccine dose after an initial 2-dose primary mRNA COVID-19 vaccine series in some immunocompromised populations may enhance immune response.

During this COCA Call, presenters will discuss the current data on COVID-19 vaccines in immunocompromised people; the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine doses, results from the August 13, 2021, Advisory Committee on Immunization Practices (ACIP) meeting, and CDC’s guidance on additional COVID-19 doses in immunocompromised people.

Date: Tuesday, August 17, 2021
Time: 2:00 pm - 3:00 pm (ET)

For additional information and to view this session, please visit the Centers for Disease Control and Prevention Emergency Preparedness and Response website at
https://emergency.cdc.gov/coca/calls/2021/callinfo_081721.asp.


AAP Town Hall: COVID-19 Hot Topics Posted 8/13/21
The AAP hosts a bi-weekly series of virtual town halls linking members with leading experts to discuss emerging issues related to the COVID-19 pandemic. The next session will be held on Thursday, August 19, 2021 at 7:00 pm CT and will address the COVID-19 variant, vaccinations, back-to-school, and other pressing topics. Join us for this informative session where you will hear from leading experts and connect with your peers.

View this and previous AAP Town Halls here.

Expert Panelists:
Sara Bode, MD, FAAP
Chairperson-elect, AAP Council on School Health
Medical Director, Nationwide Children's Hospital's Care Connection School-Based Health and Mobile Clinics

David W. Kimberlin, MD, FAAP
Editor, AAP Red Book
Sergio Stagno, MD Endowed Chair in Infectious Diseases
Co-Director of the Division of Pediatric Infectious Diseases; and Vice Chair for Clinical and Translational Research at University of Alabama at Birmingham

Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine


Guidance on Use of Palivizumab During Unusual RSV Season Posted 8/12/21
An atypical summer spike in respiratory syncytial virus (RSV) has prompted the AAP to recommend clinicians consider using palivizumab for high-risk infants in affected areas.

A typical RSV season runs from fall through spring with a peak in February. However, RSV activity was low from May 2020 to early March 2021, possibly due to COVID-19 mitigation measures. Instead, some parts of the country have seen rising rates over the last several months, prompting a health advisory from the Centers for Disease Control and Prevention (CDC).

The AAP interim guidance on administration of palivizumab during this delayed season is the same as for a typical season: Consider administering the humanized monoclonal antibody in up to five monthly doses to prevent RSV in high-risk infants and children in areas experiencing high rates of the virus.

Eligible children include premature infants, especially those born at less than 29 weeks’ gestation, infants with chronic lung disease of prematurity, infants with certain types of hemodynamically significant congenital heart disease, infants and young children with certain immunodeficiency states, and infants with pulmonary abnormalities or neurological and neuromuscular conditions that impair ability to clear secretions from the upper airway.

Clinicians should reassess the need for palivizumab at least monthly.

See the full article in AAP News.

Resources


July 2021

Neonates, Breastfeeding Infants Included in New CDC Guidance on Plague Posted 7/30/21
A new report offers recommendations on the antimicrobial treatment and prophylaxis of plague, both naturally occurring and in a bioterror attack, including guidance related to neonates and breastfeeding infants.

The evidence-based guidance published in Morbidity and Mortality Weekly Report from the Centers for Disease Control and Prevention is aimed at clinicians, public health professionals and first responders. Organizations, hospitals and communities can use the information for treating patients and in a mass casualty.

Yersina pestis, the agent that causes plague, is in the highest risk category of biologic agents and toxins. An attack would require rapid and informed decision-making by clinicians and public health agencies, according to the report Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response.

New data have become available and the Food and Drug Administration has approved additional countermeasures since plague guidelines were published in 2000. American Academy of Pediatrics experts were among those in clinical medicine, bioterrorism preparedness and public health who took part in forums beginning in 2018 and contributed to the updated publication.

See the full article in AAP News.

Also refer to the AAP Red Book Plague chapter on Red Book Online.


June 2021

What’s the Latest with the Flu Posted 6/17/21
Know Your Community Prevalence of Influenza and COVID-19
The number of influenza positive specimens reported by public health labs has remained unusually low, likely due to the COVID-19 mitigation measures in place. One pediatric influenza-associated death has been reported to CDC since October 2020. Influenza-like illness (ILI) has remained below the national baseline of 2.6%. ILI surveillance may be impacted by the COVID-19 pandemic and should be interpreted with caution (Weekly U.S. Influenza Surveillance Report | CDC). Influenza is unpredictable, and it is not possible to know how severe the next flu season will be.

The best way to be protected against the flu and its potentially serious complications is to get vaccinated with the influenza vaccine each fall.

Data on COVID-19 Among Children
Data on COVID-19 among children are updated on a weekly basis and can be found here.

Data on Community Prevalence of COVID-19
CDC COVID Data Tracker is regularly updated with information on community prevalence of COVID-19, data about testing and vaccination rates, demographic trends, and other information at the national and state level.

The Community Profile Report provides a plain language summary of key indicators for all regions, states, core-based statistical areas (CBSAs), and counties across the United States. It provides a snapshot that focuses on recent outcomes in the last seven days and changes relative to the weeks prior, and provides contextual information at the county, CBSA, state, and regional levels.

Address Missed Immunizations among the Pediatric Population
As we head into summertime, it is a good time for practices to ensure their pediatric patient population is caught up on routine childhood and adolescent immunizations that were missed due to the COVID-19 pandemic. According to CDC, public sector vaccine orders dropped 14% in 2020-2021 compared with 2019.

Clinicians and practices can employ the following strategies and resources to increase immunization rates at their practices:

  • Send reminders to families about school immunization requirements.
  • Implement provider prompts; electronic prompts in Electronic Health Records (EHRs) or notes/flags in paper charts.
  • Hold family friendly office hours.
  • Assign an Immunization Champion who can lead practice-based efforts on catch-up for your practice.
  • Provide a strong recommendation for all vaccines on the current immunization schedule.
  • Help address health beliefs and barriers about influenza and other routinely recommended vaccines.
  • Educate patients and their parents.
  • Include all recommended vaccinations at every visit. Co-administration of the COVID-19 vaccine with other vaccines is acceptable.
  • Do not miss any opportunity to vaccinate!

Click here for more information on how practices can address missed immunizations.

The AAP offers several toolkits where clinicians and providers can access sample texts, videos, and photos sized for social media platforms to promote immunization catch-up:

Apply Expertise with Flu Vaccination Clinics to COVID-19 Vaccination
Offering flu vaccination clinics for patients, and even members of patients' families, is not new for pediatricians. In fact, the COVID-19 pandemic prompted more practices to adopt new flu clinic models such as drive thru or curbside clinics, or expanded hours of existing clinics.

Pediatric practices can apply this experience to offering COVID-19 vaccination clinics. With the Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine for 12–15 year olds, pediatric practices that sign up to be providers of this vaccine may consider holding a COVID-19 vaccination clinic for adolescents. The AAP offers information, resources, and tips to help your practice host a successful vaccination event. Check out the information here.

Action Steps for Pediatricians
The Pfizer-BioNTech COVID-19 vaccine is now authorized and recommended for persons 12 years of age and up. Distribution of COVID-19 vaccine to pediatric practices is handled at the state level. States are now distributing to primary care practices. Pediatricians and their teams can prepare by doing the following:

  • Administer catch-up routine vaccinations to patients who are behind.
  • Promote COVID-19 vaccine confidence.
  • Know the COVID-19 vaccination sites in your community.

Practices that want to administer COVID-19 vaccines can consider the following:

  • Enroll to administer COVID-19 vaccine in your state
  • Learn more about providing COVID-19 vaccine to adults for those who wish to do so, including enrolling in Medicare to provide COVID-19 vaccine to seniors.

Click here for more information on what pediatricians can do now.

Additional Information
See the AAP Red Book Online Influenza Resource page, AAP Red Book Online COVID-19, and CDC FluView.

This message is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $200,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.


New 2021 Edition of Red Book now on Red Book Online! Posted 6/7/21
The newly revised and updated Red Book: 2021–2024 Report of the Committee on Infectious Diseases, 32nd Edition is now available on Red Book Online—the go-to resource for the most current information on infectious diseases.

Click "Red Book" to go directly to the Table of Contents. And, refer to the Summary of Major Changes to quickly see all the new and updated content in the Red Book 2021.

Start using the new edition of the Red Book on Red Book Online today!

Webinar—Red Book 2021 Key Updates
Dr Kimberlin, Red Book Editor, provides an overview of key updates in the 32nd edition of the Red Book in this newly recorded webinar. Topics discussed include updated vaccination recommendations (Meningococcal, Tdap/DTaP, Hepatitis A, Rotavirus), commonly treated conditions in children (eg, head lice, molluscum), travel medicine, new figures and tables to help guide the care and management of many infectious diseases (Helicobacter pylori, HIV, Hepatitis B, Measles, Tuberculosis), and much more, including a new systems-based antibiotic table that guides empiric antibiotic selection prior to knowing what the causative pathogen is! Find this new webinar on Red Book Online.

AAP Member Benefit!
Eligible AAP members can request one print copy of the 2021 Red Book® at shop.aap.org/getredbook.

AAP medical students members, international members, corresponding members, and lapsed members are not eligible. A $17 shipping and handling fee will be applied.


May 2021

Red Book Online Outbreaks: Ground Turkey – Salmonella Hadar Posted 5/14/21

This outbreak is now over.

Officials are currently investigating a multistate outbreak of Salmonella infections linked to ground turkey.

A new entry on this Salmonella Hadar outbreak has been added to the Red Book Online Outbreaks section, providing information about the outbreak and its impacts for the pediatric population.

Overseen by members of the AAP Committee on Infectious Diseases, the Outbreaks section is intended to provide pediatric health care professionals with a quick resource to get up to speed on current outbreaks and how they affect children, along with links to explore further.

Bookmark the section for regular visits, and keep an eye out for emails from Red Book Online alerting you to updates.


Mobile Apps Retirement: Red Book® Online and Pediatric Care Online™ Posted 5/14/21
On June 1, 2021, the AAP mobile apps Red Book Online (RBO) and Pediatric Care Online (PCO) will be retired to align with our efforts to provide the most updated content with the best user experience to our members and customers.

Please see the FAQs for more details about the plan as well as the best ways to access RBO and PCO content on a mobile device going forward.


American Academy of Pediatrics Calls for Children and Teens Age 12 and Up to Get the COVID-19 Vaccine Posted 5/12/21
Itasca, Ill.—In a new policy statement today, the American Academy of Pediatrics (AAP) recommends vaccinating all children ages 12 and older who are eligible for the federally authorized COVID-19 vaccine.

The AAP policy statement comes amid a discussion by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC) on the Pfizer-BioNTech vaccine for adolescents 12 years and older, including a review of the data provided by clinical trials. Earlier this week, the U.S. Food and Drug Administration granted an Emergency Use Authorization for use of the vaccine in the 12- to 15-year age group. Both steps were part of a long-standing, rigorous and transparent process that leads to the development of all vaccines.

The AAP recommends that all eligible children, teens, family and household members be vaccinated as soon as possible. Pediatricians are especially concerned about communities disproportionately impacted by the COVID-19 pandemic and are working to ensure equity in the vaccine’s distribution.

Click here for the full press statement.

AAP Policy Statement: COVID-19 Vaccines in Children and Adolescents

AAP News article: AAP, CDC recommend COVID-19 vaccine for ages 12 and older

HealthyChildren.org article: Getting Your Child Ready for the COVID-19 Vaccine


COCA Call: What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccination of Adolescents Posted 5/12/21
This COCA Call will give clinicians an overview of the Pfizer-BioNTech COVID-19 vaccination in adolescents who are 12-to-15 years of age. Clinicians will learn about the safety and efficacy of the vaccine, vaccine recommendations, and clinical guidance for using the Pfizer-BioNTech COVID-19 vaccine in adolescents in this age group.

Date: Friday, May 14, 2021
Time: 2:00 pm – 3:00 pm ET

Presenters
Sara Oliver, MD, MSPH

LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention

Kate Woodworth, MD, MPH
Medical Officer, Clinical Guidance Team
COVID-19 Response
Centers for Disease Control and Prevention

Tanya Myers, PhD, MSc
v-safe Team Co-Lead
COVID-19 Response
Centers for Disease Control and Prevention

For additional information and to view this session, please visit the CDC Emergency Preparedness and Response website at https://emergency.cdc.gov/coca/calls/2021/callinfo_051421.asp


Pediatrics Research Roundup, Preview of the Red Book—Ep. 59 Posted 5/7/21
Pediatrics On Call – In this episode Lewis First, MD, MS, FAAP, editor-in-chief of Pediatrics, is back for another edition of “First Up.” He joins hosts David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, with a bird’s-eye view of what’s in the May issue of the journal. The hosts also talk to David Kimberlin, MD, FAAP, editor of the Red Book about what to expect in the 2021 edition coming to Red Book Online June 3. Episode Website


COCA Call: Lyme Disease Updates and New Educational Tools for Clinicians Posted 5/7/21
Lyme disease is the most commonly reported vector-borne disease in the United States. The number of confirmed and probable reported cases more than doubled from 1998 to 2018. Understanding Lyme disease’s epidemiology and clinical features is valuable for clinicians in emerging areas, clinicians in endemic regions who need a refresher course, and healthcare providers in non-endemic regions who see travel-related cases.

During this COCA Call, presenters will review updates in Lyme disease epidemiology, diagnosis, treatment, and prevention and share new educational tools for both healthcare providers and their patients.

Date: Thursday, May 20, 2021
Time: 2:00 pm - 3:00 pm (ET)

Presenter
Grace Marx, MD, MPH
LCDR, U.S. Public Health Service
Medical Epidemiologist, Bacterial Diseases Branch
Division of Vector-Borne Diseases
Centers for Disease Control and Prevention

For additional information and to view this session, please visit the Centers for Disease Control and Prevention Emergency Preparedness and Response website at
https://emergency.cdc.gov/coca/calls/2021/callinfo_052021.asp.


April 2021

Next AAP Town Hall: Ask the Red Book About COVID-19 – Part 3 Posted 4/20/21
The American Academy of Pediatrics (AAP) has launched a series of virtual town halls linking members with leading experts to discuss emerging issues related to the COVID-19 pandemic. The 16th in the series, Ask the Red Book About COVID-19 – Part 3, will be held on Thursday, April 22, at 7:00 pm CT. Hear the latest on the Janssen COVID-19 vaccine pause, strategies for addressing vaccine hesitancy, SARS-CoV-2 variants, and more by leaders from the AAP Red Book Committee. Join us to hear from our experts and to connect with your peers.

View this and previous AAP Town Halls here.

Expert Panelists
David W. Kimberlin, MD, FAAP
Editor, AAP Red Book
Sergio Stagno, MD. Endowed Chair in Infectious Diseases; Co-Director of the Division of Pediatric Infectious Diseases; and Vice Chair for Clinical and Translational Research at University of Alabama at Birmingham

Bonnie Maldonado, MD, FAAP 
Chairperson, AAP Committee on Infectious Diseases 
Professor, Departments of Pediatrics and of Health Research and Policy; Chief, Division of Infectious Diseases; and Senior Associate Dean of Faculty Development, Stanford University School of Medicine

Sean O’Leary, MD, MPH, FAAP
Vice Chairperson, AAP Committee on Infectious Diseases 
Professor, Pediatrics, Sections of Pediatric Infectious Diseases and General Academic Pediatrics,
University of Colorado Anschutz Medical Campus, Children’s Hospital Colorado


The Science behind COVID-19, Antibiotic Stewardship – Episode 56 Posted 4/16/21
In this episode Sean O’Leary, MD, MPH, FAAP, vice chair of the AAP Committee on Infectious Diseases (COID), describes the characteristics of SARS-CoV-2 and what it might take to end the pandemic. Hosts David Hill, MD, FAAP and Joanna Parga-Belinkie, MD, FAAP also talk to Jeffrey S. Gerber, MD, PhD, FAAP, chair of the Antimicrobial Resistance and Stewardship Subcommittee of COID, about his efforts to end unnecessary prescribing of antibiotics in pediatrics. Click here to view.


March 2021

PCO Webinar—Hit Me with Your Best Shot: Immunizations in 2021 Posted 3/1/21
We invite you to join us on Monday, March 8, at 12:00 pm EST when Henry Bernstein, DO, MHCM, FAAP discusses the Recommended Childhood and Adolescent Immunization Schedule: United States, 2021. Objectives of this webinar include:

  • Highlight the current Recommended Childhood and Adolescent Immunization Schedule: United States, 2021.
  • Understand the rationale for the latest updates to the 2021 universal immunization schedule.
  • Understand the process for approval of COVID19 vaccine in children.

To view the webinar on Monday, March 8, please click here or use the following url:
https://event.webcasts.com/starthere.jsp?ei=1430886&tp_key=b56e77e2b2

Henry Bernstein, DO, MHCM, FAAP is a Professor of Pediatrics at the Zucker School of Medicine at Hofstra/Northwell in New York. He presently is a member of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention and the Associate Editor of Red Book Online. He is an ex-officio member of the American Academy of Pediatrics Committee on Infectious Diseases.

Dr. Bernstein taps into his extensive 36-year experience as a general pediatrician in private practice, the National Health Service Corps, and as Chief of General Academic Pediatrics at urban, suburban, and rural children’s hospitals to promote the health and well-being of children, their families, and their communities.

His private, community-based primary care (generalist) experiences, in combination with academic leadership responsibilities, have provided him with a value-added, translational science perspective, unique from many others in academia.

This tacit knowledge enables him to fulfill a lifelong passion of communicating, educating, and translating science into clinical settings, educational venues, policymaking, and media interactions to advance the health of children.


February 2021

CIIW Webinars: Updates on the 2021 Child/Adolescent and Adult Immunization Schedules Posted 2/24/21
There will be a Current Issues in Immunization Webinars: Updates on the 2021 Child/Adolescent and Adult Immunization Schedules on March 3, 2021 from 12:00-1:00 pm EST.

Moderator: Andrew Kroger, MD, MPH, Medical Officer, Communications and Education Branch, Immunization Services Division, NCIRD, CDC

Topic: Updates on the 2021 Child/Adolescent and Adult Immunization Schedules

Speakers:

  • Mark S Freedman, DVM, MPH, Veterinary Medical Officer, CDC/NCIRD
  • Patricia Wodi, Public Health Physician, CDC/NCIRD

View the recording of this webinar here.


New RBO Vaccine Status Table Posted 2/11/21
A new vaccine status table—Sars-CoV-2 vaccines—was added to the Red Book Online (RBO) Vaccine Status Table page.

This new table provides current information about five Sars-CoV-2 vaccines and pertinent information about each, including:

  • Manufacturer
  • Vaccine type
  • US Food and Drug Administration (FDA) status
  • FDA age indication
  • Dose number and interval
  • Presentation
  • Comments and links to further information

Visit the RBO Vaccine Status Table page for the latest information about recently submitted, licensed, and recommended vaccines and biologics, including status of the FDA licensure process and related American Academy of Pediatrics and Centers for Disease Control and Prevention recommendations.


January 2021

New Policy Statement on Antibiotic Stewardship in Pediatrics Posted 1/8/21
Antibiotics are among the most commonly used medications in pediatric care, but they are frequently overused, contributing to the public health crisis of antibiotic resistance. In a new policy statement, “Antibiotic Stewardship in Pediatrics,” the American Academy of Pediatrics (AAP) and Pediatric Infectious Diseases Society (PIDS) discuss the rationale for programs that monitor and evaluate the appropriate prescribing of antibiotics in inpatient and outpatient settings. The statement published in the January 2021 Pediatrics (published online Dec. 28) cites growing evidence demonstrating that antibiotic stewardship programs can reduce antibiotic overuse while improving patient outcomes. In addition to highlighting the importance of inpatient antibiotic stewardship programs, the statement emphasizes that most antibiotic prescribing occurs in the outpatient setting, and that studies show at least half of these prescriptions are considered inappropriate. AAP and PIDS note that antibiotic use can also lead to unintended, harmful effects to the patient, including Clostridioides difficile infections (CDIs), and other drug-related adverse events, such as end-organ toxicities, diarrhea, rashes, cytopenia, and anaphylaxis. In the statement, AAP and PIDS provide recommendations on personnel, infrastructure and activities required for inpatient and outpatient antibiotic stewardship programs, as well as approaches to evaluating their effectiveness.

Resources:

Close Modal

or Create an Account

Close Modal
Close Modal